X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ONCOGENE

期刊標題檢索 ONCOGENE 最新評論: It has been 100 days since the first review, and I'm done. Currently... (2025-10-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ONCOGENE]您好,您是該頁面的第 267551 位訪客。

期刊簡介
期刊名稱ONCOGENE ONCOGENE
LetPub Score
9.0
51 ratings
Rate

Reputation
9.7

Influence
8.5

Speed
8.3

期刊簡稱ONCOGENE
ISSN0950-9232
E-ISSN1476-5594
h-index312
CiteScore
CiteScoreSJRSNIPCiteScore Rank
15.402.4891.455
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Genetics
Q116 / 348
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Biology
Q134 / 410
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q125 / 233

自引率 (2023-2024)1.40%自引率趨勢
掲載範囲
Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. We propagate work that challenges standard conjecture and builds on previous studies, in particular those that lead to establishing new paradigms in the etio-pathogenesis, diagnosis, treatment, or prevention of cancers, and in processes that drive metastatic spread, and provide important insights into cancer biology beyond what has been revealed thus far.
官方網站https://www.nature.com/onc
在線稿件提交https://mts-onc.nature.com/
開放訪問No
出版商Springer Nature
主題領域医学
出版國/地區ENGLAND
發行頻率週刊
創刊年1997
每年文章數287每年文章數趨勢
黃金OA百分比38.62%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ139/320
CELL BIOLOGYSCIEQ139/204
GENETICS & HEREDITYSCIEQ116/192
ONCOLOGYSCIEQ143/328
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0950-9232%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: About 31.25%
參考鏈接
相關期刊 【ONCOGENE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 82.40
    CELLH-index: 705

    CiteScore: 74.80
    Molecular CancerH-index: 103

    CiteScore: 47.40
    Molecular PlantH-index: 85

    CiteScore: 28.20
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 31.70
    Molecular CellH-index: 356

    CiteScore: 24.40
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 29.90
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.80
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 29.00
    Nature Chemical BiologyH-index: 182

    CiteScore: 21.50
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules2057383
    CELL BIOCHEMISTRY AND BIOPHYSICS1220795
    FASEB JOURNAL796621
    NUCLEIC ACIDS RESEARCH730539
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS712789
    Molecular Cancer411304
    JOURNAL OF BIOLOGICAL CHEMISTRY404960
    GENETICS AND MOLECULAR RESEARCH345752
    International Journal of Biological Sciences345050
    CELL321723
  •  

    ONCOGENE ONCOGENE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/30)
  [ONCOGENE] 的評論撰寫評論
作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-12 10:35:24 評論於
The editorial department has made the final decision on the manuscript, but there may be some delay in the status update. Please pay close attention to any changes in status in the near future.
(0) 讚! | Adelaide Lawson

作者: 通幽阉茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-12 08:08:07 評論於
The Editor in Chief's decision is finalized and it looks like it's not good.
(0) 讚! | 通幽阉茂

作者: 慈悲凝雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-11 13:58:42 評論於
May I ask what is your current status?
(0) 讚! | 慈悲凝雨

作者: 杨家壬子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-09 09:37:41 評論於
I also want to know.
(0) 讚! | 杨家壬子

作者: Alston MacMillan


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-31 21:04:00 評論於
Is it under review now? How long have you been waiting in total?
(0) 讚! | Alston MacMillan

作者: 通幽阉茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-31 20:22:57 評論於
Submit successfully, good luck ahead.
(0) 讚! | 通幽阉茂

作者: 太山运珹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-21 11:39:15 評論於
Can you please confirm if "Waiting for Potential Reviewer Assignment" means the manuscript is in the external review process?
(0) 讚! | 太山运珹

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-21 11:11:37 評論於
The preliminary form review has been completed and the manuscript has officially entered the detailed evaluation stage for acceptance by the editor.
(0) 讚! | Adelaide Lawson

作者: 断刀俊浩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-21 10:39:49 評論於
Sharing my submission process, the relatively smooth first round of Stage Start Date Revision Received 23rd Jul 24 Waiting for Revision 21st Jun 24 Decision Made 21st Jun 24 Editor in Chief Decision Complete 19th Jun 24 Manuscript Decision complete 19th Jun 24 Editor Decision Complete 19th Jun 24 EIC Decision Started 19th Jun 24 Editor Review Completed 19th Jun 24 Receiving Editor Review Started 19th Jun 24 Review Complete 19th Jun 24 All Reviewers Assigned 6th Jun 24 Review Started 6th Jun 24 Under Consideration 29th May 24 Contacting Reviewers 29th May 24 Reviewers Assigned 29th May 24 Waiting for Potential Reviewer Assignment 21st May 24 Monitoring Editor Assigned 21st May 24 Potential Monitoring Editor Assigned 21st May 24 Under Consideration 21st May 24 Editor Assigned 17th May 24 Author Approved Converted Files 17th May 24 Submission 17th May 24 Second Round Revision Received 15th Aug 24 Waiting for Revision 14th Aug 24 Decision Made 14th Aug 24 Editor in Chief Decision Complete 10th Aug 24 Manuscript Decision complete 10th Aug 24 Editor Decision Complete 10th Aug 24 EIC Decision Started 9th Aug 24 Editor Review Completed 9th Aug 24 Receiving Editor Review Started 7th Aug 24 Review Complete 7th Aug 24 All Reviewers Assigned 29th Jul 24 Review Received 29th Jul 24 Review Started 29th Jul 24 First Reviewer Accepted 29th Jul 24 Potential Reviewers Accept 29th Jul 24 Contacting Reviewers 26th Jul 24 Reviewers Assigned 26th Jul 24 Waiting for Potential Reviewer Assignment 23rd Jul 24 Monitoring Editor Assigned 23rd Jul 24 Potential Monitoring Editor Accept 23rd Jul 24 Potential Monitoring Editor Assigned 23rd Jul 24 Editor Assigned 23rd Jul 24 Author Approved Converted Files 23rd Jul 24 Submission 23rd Jul 24 Third Round Decision Made 20th Aug 24 Editor in Chief Decision Complete 20th Aug 24 Manuscript Decision complete 20th Aug 24 Editor Decision Complete 20th Aug 24 Waiting for Potential Reviewer Assignment 20th Aug 24 Monitoring Editor Assigned 20th Aug 24 Potential Monitoring Editor Accept 20th Aug 24 Potential Monitoring Editor Assigned 20th Aug 24 Editor Assigned 15th Aug 24 Author Approved Converted Files 15th Aug 24 Submission 15th Aug 24 Overall, a very pleasant submission process with minimal need for additional experiments. The feedback from the two reviewers was positive and thorough. It seems that this journal has high standards for initial review, but the submission process was not too difficult after sending it in. Best wishes for successful submissions to everyone.
(0) 讚! | 断刀俊浩

作者: 断刀俊浩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-18 13:37:41 評論於
Review Speed: 3.0 | Submission Hit Rate: 25.0 Experience Sharing: I will share my relatively smooth first round of submission process. Stage Start Date Revision Received 23rd Jul 24 Waiting for Revision 21st Jun 24 Decision Made 21st Jun 24 Editor in Chief Decision Complete 19th Jun 24 Manuscript Decision complete 19th Jun 24 Editor Decision Complete 19th Jun 24 EIC Decision Started 19th Jun 24 Editor Review Completed 19th Jun 24 Receiving Editor Review Started 19th Jun 24 Review Complete 19th Jun 24 All Reviewers Assigned 6th Jun 24 Review Started 6th Jun 24 Under Consideration 29th May 24 Contacting Reviewers 29th May 24 Reviewers Assigned 29th May 24 Waiting for Potential Reviewer Assignment 21st May 24 Monitoring Editor Assigned 21st May 24 Potential Monitoring Editor Assigned 21st May 24 Under Consideration 21st May 24 Editor Assigned 17th May 24 Author Approved Converted Files 17th May 24 Submission 17th May 24 Second Round Revision Received 15th Aug 24 Waiting for Revision 14th Aug 24 Decision Made 14th Aug 24 Editor in Chief Decision Complete 10th Aug 24 Manuscript Decision complete 10th Aug 24 Editor Decision Complete 10th Aug 24 EIC Decision Started 9th Aug 24 Editor Review Completed 9th Aug 24 Receiving Editor Review Started 7th Aug 24 Review Complete 7th Aug 24 All Reviewers Assigned 29th Jul 24 Review Received 29th Jul 24 Review Started 29th Jul 24 First Reviewer Accepted 29th Jul 24 Potential Reviewers Accept 29th Jul 24 Contacting Reviewers 26th Jul 24 Reviewers Assigned 26th Jul 24 Waiting for Potential Reviewer Assignment 23rd Jul 24 Monitoring Editor Assigned 23rd Jul 24 Potential Monitoring Editor Accept 23rd Jul 24 Potential Monitoring Editor Assigned 23rd Jul 24 Editor Assigned 23rd Jul 24 Author Approved Converted Files 23rd Jul 24 Submission 23rd Jul 24 Third Round Decision Made 20th Aug 24 Editor in Chief Decision Complete 20th Aug 24 Manuscript Decision complete 20th Aug 24 Editor Decision Complete 20th Aug 24 Waiting for Potential Reviewer Assignment 20th Aug 24 Monitoring Editor Assigned 20th Aug 24 Potential Monitoring Editor Accept 20th Aug 24 Potential Monitoring Editor Assigned 20th Aug 24 Editor Assigned 15th Aug 24 Author Approved Converted Files 15th Aug 24 Submission 15th Aug 24 Overall, it was a very pleasant submission experience, with almost no need for additional experiments. Both reviewers provided positive feedback, with the second one being very rigorous. It seems that this journal has high requirements for initial review, but it wasn't too difficult after submission. Best wishes to all for a successful submission.
(0) 讚! | 断刀俊浩

作者: 璃沙癸巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-16 10:09:56 評論於
It's been ten days already, time flies! Thank you, wish you good luck.
(0) 讚! | 璃沙癸巳

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-15 19:59:14 評論於
Three days later.
(0) 讚! | Zona Patrick

作者: 璃沙癸巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-14 23:47:19 評論於
Excuse me, how long will you be online after you finish proofreading?
(0) 讚! | 璃沙癸巳

作者: 璃沙癸巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-14 14:02:44 評論於
How long after your proof will you be online?
(0) 讚! | 璃沙癸巳

作者: 猫巷少女普涵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-26 11:16:59 評論於
Excuse me, do I have to pay for publishing in a non-OA model? After my article was published online, I received an invoice for payment, which has left me confused. Please clarify.
(0) 讚! | 猫巷少女普涵

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-20 13:36:50 評論於
This stage has already passed the preliminary editing review and is now assigned to a processing editor who will begin a thorough review of your manuscript.
(0) 讚! | Adelaide Lawson

作者: 元魁来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-18 19:07:13 評論於
Now it's not as good as the Cancer letter, let alone the JECCR. To be honest, they are not worthy of being in the top tier anymore.
(0) 讚! | 元魁来了

作者: 寂灭嘉荣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-10 19:08:57 評論於
What stage is this Receiving Editor Review Started at?
(0) 讚! | 寂灭嘉荣

作者: 寂灭嘉荣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-09 19:22:50 評論於
Research focus: Tumor experience sharing: What stage is this Receiving Editor Review Started at?
(0) 讚! | 寂灭嘉荣

作者: 乌龙驰皓


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-26 10:39:59 評論於
In the eyes of the old professor, applying for youth is one level higher than cancer letters, and their reputations were established long ago. It's hard to say what will happen in the future, but if you don't advance, you will regress, and oncogene has regressed significantly.
(0) 讚! | 乌龙驰皓

作者: zzzmianyi


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-06-26 01:29:44 評論於
Oh, the impact factor has decreased.
(0) 讚! | zzzmianyi

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-22 20:04:16 評論於
Please translate the following paragraph into English: Just write it clearly in the article, no need to consider the submission system itself.
(0) 讚! | 是志丹吖

作者: 寂灭嘉荣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-22 14:43:38 評論於
Just submitted a paper for external review, and the impact factor has dropped to below 7. How does this journal compare to Cancer Letters?
(0) 讚! | 寂灭嘉荣

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-22 12:01:18 評論於
This is one reason, in addition to the fierce competition in tumor journals, there are too many new journals, Oncogene is a bit old, it is difficult to receive enough submissions, which is also the main reason.
(0) 讚! | 是志丹吖

作者: 震雷博超


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-21 14:21:22 評論於
Research focus: oncology; Sharing of oncology experiences: Oncogene seems to never check the original data when submitting articles, leading to serious fraud, and the quality has significantly declined in recent years. Failure to make internal adjustments will lead to major problems.
(0) 讚! | 震雷博超

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/30)

開始撰寫 [ONCOGENE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*